GLP-1 | Liraglutide | 99% high quality | white powder | weight loss

Liraglutide API is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes and obesity management.
It works by enhancing glucose-dependent secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite, which helps improve glycemic control and support weight loss.

Liraglutide API is one of the earlier long-acting GLP-1 therapies successfully commercialized.
It has been widely adopted globally under different brand formulations for diabetes control and chronic weight management, establishing a strong clinical track record over many years.
High-quality Liraglutide API produced under GMP standards is important for ensuring safety, consistency, and regulatory compliance in finished pharmaceutical products.